Not yet recruiting NCT07059910
Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Search for thyroid disorders, Laboratory test, Steroid and eltrombopage.
- Who it may be relevant to
- Registry conditions: Immune Thrombocytopenic Purpura, Thyroid Disorders. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment
Detailed description
We investigate patients with ITP for screening of thyroid disorders and how to deal with it and effect of this on the ttt
Interventions
- Diagnostic test Search for thyroid disorders
TSH , FT3 , FT4 - Diagnostic test Laboratory test
Search for anti thyroid antibodies - Drug Steroid and eltrombopage
See when we treat thyroid disorders, will patient respond to steroid or eltrombopage?
Primary outcome measures
- Assess the frequency of thyroid disorders in patients with IT [Time frame: Assess the frequency of thyroid disorders in patients with IT]
- Evaluate the treatment of thyroid disorders in improvement in platelets count. [Time frame: Evaluate the treatment of thyroid disorders in improvement in platelets count.]
Eligibility criteria
Inclusion criteria
- ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.
- refractory ITP patients.
Exclusion criteria
- patients with history of thyroidectomy
- patients with history of drug induced ITP
- patients with history of HCV, HBV and HIV infection.
- Patients who refuse to contribute in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07059910 · ITP and thyroid disorders